Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat

Experimental Neurology

Volumn 152, Issue 2, 1998, Pages 259-277

  Kirik, Deniz ^a   Rosenblad, Carl ^a   Björklund, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

6 hydroxydopamine; Cell loss; Parkinson's disease; Paw use; Sensorimotor behavior; Stepping; Stereology; Tyrosine hydroxylase

Indexed keywords

OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL LOSS; DOPAMINERGIC SYSTEM; FEMALE; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEREOLOGY;

EID: 0032143368     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6848     Document Type: Article

References (46)

1. Ballard P. A., Tetrud J. W., Langston J. W. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,5,6-tetrahydropterine (MPTP): Seven cases. Neurology. 35:1985;949-956.
2. Barnéoud P., Parmentier S., Mazadier M., Miquet A., Boireau P., Dubédat P., Blanchard J-C. Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat. Neuroscience. 67:1995;837-848.
3. Berger K., Przedborski S., Cadet J. L. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal injection in rats. Brain Res. Bull. 26:1991;301-307.
4. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberg F. Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci. 20:1973;415-455.
5. Björklund A., Lindvall O. Dopamine containing systems in the CNS. Handbook of Chemical Neuroanatomy. 1984;Elsevier, Amsterdam. p. 55-122.
6. Brooks, D. J. 1994, Functional imaging of movement disorders, Movement Disorders 3, C. D. MarsdenS. Fahn, 65, 87, Butterworth-Heinemann, Oxford.
7. Cadet J. L., Last R., Kostic V., Przedborski S., Jackson Lewis V. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen. Brain Res. Bull. 26:1991;707-713.
8. Cadet J. L., Zhu S. M. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: Quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat. Brain Res. 595:1992;316-326.
9. Carli M., Everden J. L., Robbins T. W. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature. 313:1985;679-682.
10. Cousins M. S., Salamone J. D. Involvement of ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Neuroscience. 79:1996;849-859.
11. Cousins M. S., Sokolowski D., Salamone J. D. Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol. Biochem. Behav. 46:1993;943-951.
12. Doucet G., Brundin P., Descarries L., Björklund A. Effect of prior denervation on survival and fiber outgrowth from intrastriatal fetal mesencephalic grafts. Eur. J. Neurosci. 2:1990;279-290.
13. Dunnett S. B., Björklund A., Schmidt R. H., Stenevi U., Iversen S. D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioral recovery in the rats with unilateral implants of nigral cell suspensions. Acta Physiol. Scand. 522:1983;29-37.
14. Dunnett S. B., Iversen S. D. Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the neostriatum. Brain Res. 248:1982;121-127.
15. Fearnley J. M., Lees A. J. Ageing is not involved in the pathophysiology of Parkinson's disease. Brain. 114:1991;2283-2301.
16. Gibb, W. R. G. A. J. Lees, 1994, Pathological clues to the cause of Parkinson's disease, Movement Disorders 3, C. D. MarsdenS. Fahn, 147, 166, Butterworth-Heinemann, Oxford.
17. Gundersen H. J. G., Jensen E. B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147:1987;229-263.
18. Hefti F., Melamed E., Wurtman R. J. Partial lesions of the dopaminergic nigrostriatal system in the rat brain: biochemical characterization. Brain Res. 195:1980;123-137.
19. 3. Brain Res. 211:1981;285-292.
20. Ichitani Y., Okamura H., Masamoto Y., Nagatsu I., Abata Y. Degeneration of nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res. 549:1991;350-353.
21. Janson A. M., Moller A. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience. 57:1993;931-941.
22. Kish S. J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of Parkinson's disease. N. Engl. J. Med. 318:1988;876-880.
23. Lee C. S., Sauer H., Björklund A. Dopaminergic neuronal degeneration and motor impairments following lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience. 72:1996;641-653.
24. Lindner M. D., Plone M. A., Francis J. M., Blaney T. J., Salamone J. D., Emerich D. F. Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task. Behav. Brain Res. 86:1997;25-40.
25. Mandel R., Brundin P., Björklund A. The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur. J. Neurosci. 2:1990;888-894.
26. Marshall J. F., Ungerstedt U. Striatal efferents play a role in maintaining rotational behavior in the rat. Science. 198:1977;62-64.
27. McGeer P. L., Itagaki S., Akiyama H., McGeer E. G. Rate of cell death in parkinsonism indicate active neuropathological process. Ann. Neurol. 24:1988;574-576.
28. McGeer P. L., McGeer E. G., Suzuki J. S. Ageing and extrapyramidal function. Arch. Neurol. 34:1977;33-35.
29. Montoya C. P., Astell S., Dunnett S. B. Effects of nigral and striatal grafts on skilled forelimb use in the rat. Prog. Brain Res. 82:1990;459-466.
30. Montoya C. P., Campbell H. L., Pemberton K. D., Dunnett S. B. The 'staircase test': A measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods. 36:1991;219-228.
31. Nikkhah G., Cunningham M. G., Jödicke A., Knappe U., Björklund A. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience. 56:1993;33-43.
32. Nyberg P., Nordberg A., Wester P., Winblad B. Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's patients. Neurochem. Pathol. 1:1983;193-202.
33. Olsson M., Nikkhah G., Bentlage C., Björklund A. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:1995;3863-3875.
34. Pakkenberg B., Moller A., Gundersen H. J. G., Mouritzen Dam A., Pakkenberg H. The abolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry. 54:1991;30-33.
35. Pakkenberg H., Brody H. The number of nerve cells in the substantia nigra in paralysis agitans. Acta Neuropathol. 5:1965;320-324.
36. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, San Diego.
37. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togaski D. M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-637.
38. Rioux L., Gaudin D. P., Gagnon C., Di Paolo T., Bédard P. J. Decrease of behavioral and biochemical denervation supersensitivity of the rat striatum by nigral transplants. Neuroscience. 44:1991;75-83.
39. Sabol K. E., Neill D. B., Wages S. A., Church W. H., Justice J. B. Dopamine depletion in a striatal subregion disrupts performance of a skilled motor task in the rat. Brain Res. 335:1985;33-43.
40. Sauer H., Oertel W. H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde and immunocytochemical study in the rat. Neuroscience. 59:1994;401-415.
41. Schallert T., De Ryck M., Whishaw I. Q., Teitelbaum P. Excessive bracing reactions and their control by atropine and L-dopa in an animal analog of Parkinsonism. Exp. Neurol. 64:1979;33-43.
42. Schallert T., Norton D., Jones T. A. A clinically relevant unilateral rat model of Parkinsonian akinesia. J. Neural Transplant. Plast. 3:1992;332-333.
43. Schmidt R. H., Björklund A., Stenevi U., Dunnett S. B., Gage F. H. Intracerebral grafting neuronal cell suspension implants as assessed by measurement of dopamine synthesis and metabolism. Acta Physiol. Scand. 522:1983;19-28.
44. Ungerstedt U., Arbuthnott G. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
45. West M. J., Slomianka L., Gundersen H. J. G. Unbiased stereological estimation of the total number of neurons of the rat hippocampus using the optical fractionator. Anat. Rec. 231:1991;482-497.
46. Winkler C., Sauer H., Lee C. S., Björklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 16:1996;7206-7215.